Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
EuMCV4
- Development stage
- Phase 1
- Lead developer
- EuBiologics
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
EuMCV4 is a quadrivalent meningococcal conjugate vaccine developed by EuBiologics Co., Ltd. It is designed to protect against invasive meningococcal disease caused by *Neisseria meningitidis* serogroups A, C, W-135, and Y. The vaccine utilizes capsular polysaccharides from these four serogroups conjugated to the CRM197 protein, which acts as a carrier to enhance the immune response. It aims to induce immunity by stimulating the production of bactericidal antibodies.
- Brand names
- EG-MCV4EG-MCV-4EG-MCV 4
- Other names
- Meningococcal (Groups A, C, W-135 and Y) Conjugate VaccineMeningococcal (Groups A, C, Y, and W-135) Conjugate VaccineMeningococcal Quadrivalent Conjugate Vaccine
02
Targets
Neisseria meningitidis group C capsular polysaccharideNmA CPS (Neisseria meningitidis group A capsular polysaccharide)Group Y CPS (Neisseria meningitidis group Y capsular polysaccharide)MenW CPS (Neisseria meningitidis serogroup W capsular polysaccharide)
Beyond the preview
Go deeper on EuMCV4.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on EuMCV4.